Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$1.27 - $8.28 $350,437 - $2.28 Million
-275,935 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$6.08 - $10.44 $1.64 Million - $2.82 Million
269,758 Added 4367.14%
275,935 $2.71 Million
Q1 2021

May 13, 2021

SELL
$8.35 - $12.39 $4,483 - $6,653
-537 Reduced 8.0%
6,177 $54,000
Q4 2020

Feb 16, 2021

BUY
$8.02 - $12.81 $18,197 - $29,065
2,269 Added 51.05%
6,714 $69,000
Q3 2020

Nov 12, 2020

BUY
$6.96 - $9.12 $2,923 - $3,830
420 Added 10.43%
4,445 $40,000
Q2 2020

Aug 13, 2020

BUY
$7.14 - $14.41 $24,975 - $50,406
3,498 Added 663.76%
4,025 $29,000
Q1 2020

May 14, 2020

SELL
$5.89 - $17.67 $212 - $636
-36 Reduced 6.39%
527 $5,000
Q4 2019

Feb 14, 2020

BUY
$9.13 - $13.9 $5,140 - $7,825
563 New
563 $7,000

Others Institutions Holding GRTX

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.07M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.